Copertina

Exercise intensity matters: A review on evaluating the effects of aerobic exercise intensity on muscle‐derived neuroprotective myokines

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Navabeh Zare, David J. Bishop, Itamar Levinger, Mark A. Febbraio, James R. Broatch
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Alzheimer's & Dementia: Translational Research & Clinical Interventions
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Lower CD8+ T‐cell senescence partially mediates the neuroprotection of higher aerobic fitness
di: Bernadette A. Fausto, et al.
Pubblicazione: (2026)

Worth their weight in gray matter? A narrative review of cost‐effectiveness analyses of monoclonal antibodies for Alzheimer's disease
di: Tuyet Thao Nguyen, et al.
Pubblicazione: (2026)

Low intrinsic capacity is associated with a blunted exercise‐induced cognitive enhancement in physically active middle‐aged and older adults
di: Brandon A. Yates, et al.
Pubblicazione: (2025)

Utilizing MCID for evaluating clinical relevance of AD therapeutic interventions
di: Jamie L. Hamilton, et al.
Pubblicazione: (2025)

Omics‐derived biological modules reflect tau positron emission tomography in Alzheimer's disease
di: Si‐Chun Gu, et al.
Pubblicazione: (2025)

Developing, implementing, and evaluating the first national Memory and Cognition Clinic Guidelines in Australia
di: Inga Mehrani, et al.
Pubblicazione: (2025)

Brain networks modulating the relationship between white matter volume and cognition
di: Osamu Katayama, et al.
Pubblicazione: (2026)

Systematic review and meta‐analysis of antipsychotic discontinuation in dementia
di: Sophie Roche, et al.
Pubblicazione: (2025)

Diabetes mellitus exacerbates changes in white matter hyperintensity shapes and volume: A longitudinal study
di: Shihao Xu, et al.
Pubblicazione: (2025)

Hearing loss and cognitive decline: Prioritizing equity in a world in which hearing health matters
di: Carrie L. Nieman, et al.
Pubblicazione: (2024)

Locus coeruleus alterations in dementia with Lewy bodies: A systematic review
di: Anaëlle Bain, et al.
Pubblicazione: (2026)

Comparison of sample characteristics of Wisconsin Alzheimer's Disease Research Center participants with the Wisconsin state population—An evaluation of the recruitment effort
di: Yue Ma, et al.
Pubblicazione: (2025)

Statin use and dementia risk: A systematic review and updated meta‐analysis
di: Fernando Luiz Westphal Filho, et al.
Pubblicazione: (2025)

Rural–urban disparities of Alzheimer's disease and related dementias: A scoping review
di: Mackenzie Kramer, et al.
Pubblicazione: (2025)

Sex differences in blood pressure hemodynamics and white matter hyperintensity volume across racial ethnic groups—HABS‐HD
di: Cellas A. Hayes, et al.
Pubblicazione: (2026)

Critical evaluation of real‐world evidence of repurposable medicines in the Alzheimer's disease drug development pipeline using a target trial emulation
di: Reina Tonegawa‐Kuji, et al.
Pubblicazione: (2025)

Data‐driven discovery of associations between prescribed drugs and dementia risk: A systematic review
di: Benjamin R. Underwood, et al.
Pubblicazione: (2025)

Chronic cerebral hypoperfusion‐induced myelin loss in normal‐appearing white matter correlates with cognitive decline: insights from moyamoya disease
di: Xinfeng Yu, et al.
Pubblicazione: (2025)

Biological effects of sodium phenylbutyrate and taurursodiol in Alzheimer's disease
di: Steven E. Arnold, et al.
Pubblicazione: (2024)

Implications of practice effects for the design of Alzheimer clinical trials
di: Jasmin A. Duehring, et al.
Pubblicazione: (2025)

Assessing social connection for long‐term care home residents: A scoping review of measure content
di: Madalena P. Liougas, et al.
Pubblicazione: (2024)

From companionship to science: the importance of dogs in advancing translational research on Alzheimer's disease – a scoping review
di: Heloísa Máximo Ribeiro, et al.
Pubblicazione: (2026)

The interaction effect of physical activity and sleep on cognitive function in stroke
di: Ryan G. Stein, et al.
Pubblicazione: (2025)

Cost‐effectiveness of a multicomponent intervention against cognitive decline
di: Christian Brettschneider, et al.
Pubblicazione: (2025)

Modeling amyloid plaque turnover dynamics improves characterization of drug effects
di: Eline van Maanen, et al.
Pubblicazione: (2025)

Effect of long‐term treatment with memantine on mortality in patients with major cognitive disorders: A systematic review and meta‐analysis
di: Victoria Zolnowski‐Kolp, et al.
Pubblicazione: (2025)

APOE ‐associated disease risk and sex‐specific effects in Egyptian Alzheimer's disease: an exploratory study
di: Mai Othman, et al.
Pubblicazione: (2026)

Assessing social connection for long‐term care home residents: Systematic review using COnsensus‐based Standards for the selection of health Measurement INstruments guidelines
di: Neha Dewan, et al.
Pubblicazione: (2024)

Blood biomarkers for Alzheimer's disease are correlated with measures of agitation and cognition in a randomized trial assessing the effects of escitalopram on agitation
di: Maansi Barnwal, et al.
Pubblicazione: (2026)

Cognitive and Alzheimer's disease biomarker effects of oral nicotinamide riboside (NR) supplementation in older adults with subjective cognitive decline and mild cognitive impairment
di: Chao‐Yi Wu, et al.
Pubblicazione: (2025)

Erratum to “Evaluation of efficiency and effectiveness of different recruitment strategies for the FINGER‐NL multidomain lifestyle intervention trial via the Dutch Brain Research Registry”
Pubblicazione: (2025)

Blood‐based biomarker prescreening with different testing combinations and cutoffs: A simulation study examining efficacy and cost‐effectiveness in Alzheimer's disease prevention studies
di: Kenichiro Sato, et al.
Pubblicazione: (2025)

The words community dwelling, Spanish‐preferring Mexican/Mexican American adults use to talk about Alzheimer's disease and genetic testing: Implications for education and outreach
di: Jamie C. Fong, et al.
Pubblicazione: (2026)

Pooling Alzheimer's disease clinical trial data to develop personalized medicine approaches is easier said than done: A proof‐of‐principle study and call to action
di: Mark A. Dubbelman, et al.
Pubblicazione: (2024)

Physical activity as a resistance or resilience mechanism in Down syndrome Alzheimer's disease
di: Victoria L. Fleming, et al.
Pubblicazione: (2025)

More fit KL‐VS heterozygotes have more favorable AD‐relevant biomarker profiles
di: Mackenzie Jarchow, et al.
Pubblicazione: (2025)

The impact of estimated cardiorespiratory fitness on Alzheimer's disease biomarkers and their relationships with cognitive decline
di: Adam J Paulsen, et al.
Pubblicazione: (2025)

Profiling the needs of dementia caregivers in a Brazilian cross‐sectional study
di: Alan Cronemberger Andrade, et al.
Pubblicazione: (2025)

Clinically meaningful outcomes in Alzheimer's disease and Alzheimer's disease related dementias trials
di: Luke E. Stoeckel, et al.
Pubblicazione: (2025)

Issue Information
Pubblicazione: (2026)